Vyne Therapeutics Inc (VYNE)

12:26 PM

What insider trading reveals about VYNE Therapeutics Inc. stockResistance Breakout Alerts & See Risk Factors Before Making Any Move - ulpravda.ru

12:26 PM

Jan 02, 2026

VYNE Therapeutics Inc. (NASDAQ:VYNE) Short Interest Down 18.2% in December - Defense World

Jan 02, 2026

Dec 26, 2025

VYNE Therapeutics Inc. (VYNE) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 26, 2025

Dec 25, 2025

VYNE SEC FilingsVyne Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 25, 2025

Dec 21, 2025

Vyne Therapeutics shares surge on merger deal with Yarrow Bioscience - MSN

Dec 21, 2025

Dec 21, 2025

Why VYNE Therapeutics Inc. stock remains resilient2025 EndofYear Setup & Entry Point Confirmation Signals - Улправда

Dec 21, 2025

Dec 20, 2025

VYNE Therapeutics to merge with Yarrow Bioscience, secures $200M financing; shares up - MSN

Dec 20, 2025

Dec 20, 2025

Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire

Dec 20, 2025

Dec 20, 2025

Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.

Dec 20, 2025

Dec 20, 2025

How VYNE Therapeutics Inc. stock compares to industry benchmarksMarket Sentiment Review & AI Enhanced Market Trend Forecasts - Улправда

Dec 20, 2025

Dec 19, 2025

Should I hold or sell VYNE Therapeutics Inc. stock in 2025Market Activity Summary & High Conviction Trade Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Is VYNE Therapeutics Inc. stock resilient to inflation2025 Market Outlook & AI Based Buy and Sell Signals - Улправда

Dec 19, 2025

Dec 18, 2025

Shareholder Alert: The Ademi Firm investigates whether VYNE Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders - PR Newswire

Dec 18, 2025

Dec 18, 2025

Risk Analysis: Will VYNE Therapeutics Inc. stock benefit from automation2025 Buyback Activity & Real-Time Volume Surge Alerts - Улправда

Dec 18, 2025

Dec 18, 2025

3 Penny Stocks to Watch Now, 12/18/25 - TipRanks

Dec 18, 2025

Dec 18, 2025

VYNE Therapeutics to merge with Yarrow Bioscience in $200 million deal - Investing.com

Dec 18, 2025

Dec 17, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of VYNE Therapeutics Inc. (NASDAQ: VYNE) - PR Newswire

Dec 17, 2025

Dec 17, 2025

VYNE Therapeutics Inc. (VYNE) Stock: Soars 55.45% on Merger Announcement with Yarrow Bioscience - parameter.io

Dec 17, 2025

Dec 17, 2025

Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience - PharmExec.com

Dec 17, 2025

Dec 17, 2025

VYNE Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of VYNE Therapeutics Inc. is Fair to Shareholders - The AI Journal

Dec 17, 2025

Dec 17, 2025

VYNE Therapeutics: A New Chapter in Autoimmune Disease with Yarrow Bioscience - FinancialContent

Dec 17, 2025

Dec 17, 2025

Transcript : VYNE Therapeutics Inc., Yarrow Bioscience, Inc.M&A Call - marketscreener.com

Dec 17, 2025

Dec 17, 2025

VYNE Therapeutics (VYNE) Surges on Merger with Yarrow Bioscience - GuruFocus

Dec 17, 2025

Dec 17, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Dec 17, 2025

Dec 17, 2025

Crude Oil Rises Over 1%; General Mills Earnings Top Views - Benzinga

Dec 17, 2025

Dec 17, 2025

Yarrow Bioscience, Inc. entered into an Agreement and Plan of Merger and Reorganization to acquire VYNE Therapeutics Inc. in a reverse merger transaction. - marketscreener.com

Dec 17, 2025

Dec 17, 2025

VYNE: VYNE and Yarrow merge to advance YB-101 for Graves' disease and TED, backed by $200M funding - TradingView — Track All Markets

Dec 17, 2025

Dec 17, 2025

Dow Jumps 150 Points; Jabil Posts Upbeat Earnings - Benzinga

Dec 17, 2025

Dec 17, 2025

Vyne Therapeutics stock soars after merger with Yarrow Bioscience By Investing.com - Investing.com Nigeria

Dec 17, 2025

Dec 17, 2025

Vyne Therapeutics stock soars after merger with Yarrow Bioscience - Investing.com

Dec 17, 2025

Dec 17, 2025

VYNE Announces Merger with Yarrow Bioscience, Focuses on TSHR An - GuruFocus

Dec 17, 2025

Dec 17, 2025

VYNE Therapeutics Announces Merger with Yarrow Bioscience - TipRanks

Dec 17, 2025

Dec 17, 2025

VYNE Therapeutics, Yarrow Bioscience enter merger agreement - TipRanks

Dec 17, 2025

Dec 17, 2025

Vyne Therapeutics and Yarrow Bioscience announce merger agreement - marketscreener.com

Dec 17, 2025

Dec 17, 2025

VYNE FinancialsIncome Statement - Quiver Quantitative

Dec 17, 2025

Dec 17, 2025

VYNE and Yarrow Bioscience to merge in all-stock transaction - Investing.com

Dec 17, 2025

Dec 17, 2025

VYNE Therapeutics (VYNE) plans merger with Yarrow, Yarrow to own 97% - Stock Titan

Dec 17, 2025

Dec 17, 2025

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement - marketscreener.com

Dec 17, 2025

Dec 16, 2025

VYNE Therapeutics Inc Stock Analysis and ForecastPrice Action Trading & Backtest Your Strategy Before You Risk Money - earlytimes.in

Dec 16, 2025

Dec 15, 2025

[Form 4] VYNE Therapeutics Inc. Insider Trading Activity - Stock Titan

Dec 15, 2025

Dec 15, 2025

VYNE Therapeutics (VYNE) director reports annual 20,000 option grant - Stock Titan

Dec 15, 2025

Dec 15, 2025

VYNE Therapeutics (VYNE) reports 20,000 stock options granted to director - Stock Titan

Dec 15, 2025

Dec 15, 2025

Is it possible to buy VYNE Therapeutics Inc(VYNE) shares at a good price now? - uspostnews.com

Dec 15, 2025

Dec 13, 2025

VYNE Therapeutics Approves Director Elections and Proposals - The Globe and Mail

Dec 13, 2025

Dec 12, 2025

[8-K] VYNE Therapeutics Inc. Reports Material Event | VYNE SEC FilingForm 8-K - Stock Titan

Dec 12, 2025

Dec 10, 2025

VYNE Therapeutics Inc (VYNE) Performance and Fundamentals Dashboard tells a completely different story - setenews.com

Dec 10, 2025

Dec 04, 2025

Can VYNE Therapeutics Inc. stock resist sector downturnsTrade Exit Summary & Low Risk Profit Maximizing Plans - Newser

Dec 04, 2025